Cited by 44T-cell and B-cell ImmunologyTryptophan and brain disordersGut microbiota and health

Blunted Expansion of Regulatory T Lymphocytes Is Associated With Increased Bacterial Translocation in Patients With Major Depressive Disorder

Open access
Alvarez-Mon, Miguel Angel, Gomez-Lahoz, Ana Maria, Orozco, Arantxa, Lahera, Guillermo, Sosa-Reina, M. Dolores, Diaz, David, Albillos, Agustin, Quintero, Javier +3 more·2021·Frontiers in Psychiatry

Abstract

Background: Major Depressive Disorder (MDD) is associated with both proinflammatory and adaptive immune response abnormalities. Regulatory T lymphocytes (Tregs), a subtype of CD4+ T cells, are relevant for maintaining immune-inflammatory system homeostasis and control of inflammation such as the kind potentially induced by the interactions between the intestinal microbiome and gut mucosa. We investigated the Treg population and its distribution along their stages of differentiation/activation, as well as its function in MDD patients without concomitant diseases. We also studied the potential association between Treg alterations, intestinal barrier damage, and bacterial translocation. Methods: 30 MDD patients and 20 healthy controls were studied. The levels of circulating CD25FoxP3+ Tregs and their distribution on the naïve (T N), effector (T E), central (T CM), and effector memory(T EM) differentiation/activation stages were analyzed using polychromatic flow cytometry. Chemokine receptors (CCR) 2, 5, and 6, and the intracytoplasmic IL-10 expression by the Tregs were also analyzed. The serum IL-10 was measured using Luminex. The serum levels of zonulin and the intestinal fatty acid-binding protein (I-FABP), both markers of gut barrier function, and the LPS-binding protein (LBP), a marker of bacterial translocation, were measured using an enzyme-linked immunosorbent assay. Results: MDD patients had increased number of circulating Tregs cells with enhanced number of Tregs at the T N, T E, T CM, and T EM stages. The percentage of Tregs cells at T N stage was significantly higher in MDD patients. The percentage of Tregs that expressed CCR2 and CCR6 was increased as well as those expressing IL-10. MDD patients had significantly increased levels of circulating I-FABP and LBP. MDD patients with high LBP levels had a significant reduction in the number of circulating Tregs compared to normal-LBP MDD patients. Conclusions: MDD patients showed an expansion of circulating Tregs and their CD25 high FoxP3+ and CD25 low FoxP3+ subsets throughout the different stages of CD4+ T lymphocyte differentiation/activation. Tregs also showed an increased frequency of cells expressing CCR6 and CCR2. IL-10 Treg production was also enhanced in MDD patients that concurrently had increased serum IL-10 levels. However, this Treg expansion was blunted in MDD patients with gut barrier damage and increased bacterial translocation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpsyt.2020.591962

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent evidence suggests the involvement of the immune system in several psychiatric conditions; one of the most studied in this respect is depression.

    “Recent evidence suggests the involvement of the immune system in several psychiatric conditions [203–205]; one of the most studied in this respect is depression [206–208].”

    From Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review (2022) · cites this paper as [206]

    The Introduction (page unavailable) describes extensive research linking immune dysfunction with major depressive disorder, including consistent reports of elevated proinflammatory cytokines. It does not compare depression with other psychiatric conditions, so it does not establish that depression is one of the most studied in this respect. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. [2]Mathers CD Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. (2006) 3: e442. 10.1371/journal.pmed.0030442 17132052 PMC1664601 · DOI · Paper page
  2. [3]Park LT Zarate CA Depression in the primary care setting. N Engl J Med. (2019) 380: 559– 68. 10.1056/NEJMcp1712493 30726688 PMC6727965 · DOI
  3. [6]Attai DJ Cowher MS Al-Hamadani M Schoger JM Staley AC Landercasper J. Twitter social media is an effective tool for breast cancer patient education and support: patient-reported outcomes by survey. J Med Internet Res. (2015) 17: e188. 10.2196/jmir.4721 26228234 PMC4705354 · DOI · Paper page
  4. [7]Roy T Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. (2012) 142(Suppl.): S8– 21. 10.1016/S0165-0327(12)70004-6 23062861 · DOI · Paper page
  5. [8]Morrison MF Petitto JM Ten Have T Gettes DR Chiappini MS Weber AL Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. (2002) 159: 789– 96. 10.1176/appi.ajp.159.5.789 11986133 · DOI
  6. [9]Meesters JJ Bremander A Bergman S Petersson IF Turkiewicz A Englund M. The risk for depression in patients with ankylosing spondylitis: a population-based cohort study. Arthritis Res Ther. (2014) 16: 418. 10.1186/s13075-014-0418-z 25209603 PMC4180137 · DOI
  7. [10]Jones KA Thomsen C. The role of the innate immune system in psychiatric disorders. Mol Cell Neurosci. (2013) 53: 52– 62. 10.1016/j.mcn.2012.10.002 23064447 · DOI · Paper page
  8. [11]Haapakoski R Ebmeier KP Alenius H Kivimäki M. Innate and adaptive immunity in the development of depression: an update on current knowledge and technological advances. Prog Neuropsychopharmacol Biol Psychiatry. (2016) 66: 63– 72. 10.1016/j.pnpbp.2015.11.012 26631274 PMC4736094 · DOI · Paper page
  9. [13]Leserman J Barroso J Pence BW Salahuddin N Harmon JL. Trauma, stressful life events and depression predict HIV-related fatigue. AIDS Care. (2008) 20: 1258– 65. 10.1080/09540120801919410 18608079 PMC2603249 · DOI
  10. [14]Toben C Baune BT. An act of balance between adaptive and maladaptive immunity in depression: a role for T lymphocytes. J Neuroimmune Pharmacol. (2015) 10: 595– 609. 10.1007/s11481-015-9620-2 26133121 · DOI
  11. [17]Campbell DJ Koch MA. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol. (2011) 11: 119– 30. 10.1038/nri2916 21267013 PMC3289970 · DOI · Paper page
  12. [18]Miyara M Yoshioka Y Kitoh A Shima T Wing K Niwa A. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity. (2009) 30: 899– 911. 10.1016/j.immuni.2009.03.019 19464196 · DOI · Paper page
  13. [19]Sakaguchi S Miyara M Costantino CM Hafler DA FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. (2010) 10: 490– 500. 10.1038/nri2785 20559327 · DOI
  14. [20]Miyao T Floess S Setoguchi R Luche H Fehling HJ Waldmann H. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity. (2012) 36: 262– 75. 10.1016/j.immuni.2011.12.012 22326580 · DOI
  15. [21]Komatsu N Mariotti-Ferrandiz ME Wang Y Malissen B Waldmann H Hori S. Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci USA. (2009) 106: 1903– 8. 10.1073/pnas.0811556106 19174509 PMC2644136 · DOI
  16. [22]Shevyrev D Tereshchenko V. Treg heterogeneity, function, and homeostasis. Front Immunol. (2019) 10: 3100. 10.3389/fimmu.2019.03100 31993063 PMC6971100 · DOI
  17. [23]Maecker HT McCoy JP Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat Rev Immunol. (2012) 12: 191– 200. 10.1038/nri3158 22343568 PMC3409649 · DOI
  18. [24]Wang YM Ghali J Zhang GY Hu M Wang Y Sawyer A Development and function of Foxp3(+) regulatory T cells. Nephrology. (2016) 21: 81– 5. 10.1111/nep.12652 26461175 · DOI
  19. [25]Cook KW Letley DP Ingram RJM Staples E Skjoldmose H Atherton JC. CCL20/CCR6-mediated migration of regulatory T cells to the helicobacter pylori-infected human gastric mucosa. Gut. (2014) 63: 1550– 9. 10.1136/gutjnl-2013-306253 24436142 PMC4173663 · DOI
  20. [26]Loyher P-L Rochefort J Baudesson de Chanville C Hamon P Lescaille G Bertolus C. CCR2 influences T regulatory cell migration to tumors and serves as a biomarker of cyclophosphamide sensitivity. Cancer Res. (2016) 76: 6483– 94. 10.1158/0008-5472.CAN-16-0984 27680685 · DOI
  21. [27]Kailashiya V Singh U Rana R Singh NK Dash D Kailashiya J. Regulatory T cells and their association with serum markers and symptoms in systemic lupus erythematosus and rheumatoid arthritis. Immunol Invest. (2019) 48: 64– 78. 10.1080/08820139.2018.1527852 30325682 · DOI
  22. [30]Mohd Ashari NS Mohamed Sanusi SNF Mohd Yasin MA Che Hussin CM Wong KK Shafei MN. Major depressive disorder patients on antidepressant treatments display higher number of regulatory T cells. Malays J Pathol. (2019) 41: 169– 76. 31427552
  23. [31]Grosse L Hoogenboezem T Ambrée O Bellingrath S Jörgens S de Wit HJ. Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation. Brain Behav Immun. (2016) 54: 38– 44. 10.1016/j.bbi.2015.12.003 26674997 · DOI
  24. [32]Suzuki H Savitz J Kent Teague T Gandhapudi SK Tan C Misaki M. Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: association with sleep disturbance. Brain Behav Immun. (2017) 66: 193– 200. 10.1016/j.bbi.2017.06.011 28645775 PMC5650936 · DOI
  25. [33]Round JL Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA. (2010) 107: 12204– 9. 10.1073/pnas.0909122107 20566854 PMC2901479 · DOI · Paper page
  26. [35]Albillos A De-la-Hera A Alvarez-Mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infection in cirrhotic patients with ascites. Lancet. (2004) 363: 1608– 10. 10.1016/S0140-6736(04)16206-5 15145636 · DOI
  27. [36]American Psychiatric Association (APA) Diagnostic and Statistical Manual of Mental Disorders. (5th ed). Washington, DC: American Journal of Psychiatry (2013). 10.1176/appi.books.9780890425596 · DOI · Paper page
  28. [37]Sheehan D V Lecrubier Y Sheehan KH Amorim P Janavs J Weiller E The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. (1998) 59(Suppl 2: 22– 33. 9881538
  29. [38]Monserrat J Sánchez MÁ de Paz R Díaz D Mur S Reyes E. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients. Cytometry B Clin Cytom. (2014) 86: 32– 43. 10.1002/cyto.b.21120 24166938 · DOI
  30. [41]Tao JH Cheng M Tang JP Liu Q Pan F Li XP. Foxp3, regulatory T cell, and autoimmune diseases. Inflammation. (2017) 40: 328– 39. 10.1007/s10753-016-0470-8 27882473 · DOI
  31. [42]Snijders G Schiweck C Mesman E Grosse L De Wit H Nolen WA. A dynamic course of T cell defects in individuals at risk for mood disorders. Brain Behav Immun. (2016) 58: 11– 7. 10.1016/j.bbi.2016.05.007 27181178 · DOI
  32. [43]Li Y Xiao B Qiu W Yang L Hu B Tian X. Altered expression of CD4+CD25+ regulatory T cells and its 5-HT1a receptor in patients with major depression disorder. J Affect Disord. (2010) 124: 68– 75. 10.1016/j.jad.2009.10.018 19900711 · DOI · Paper page
  33. [44]Grosse L Carvalho LA Birkenhager TK Hoogendijk WJ Kushner SA Drexhage HA. Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy. Psychopharmacology. (2016) 233: 1679– 88. 10.1007/s00213-015-3943-9 25953327 · DOI
  34. [45]Tang Q Adams JY Penaranda C Melli K Piaggio E Sgouroudis E. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. (2008) 28: 687– 97. 10.1016/j.immuni.2008.03.016 18468463 PMC2394854 · DOI · Paper page
  35. [46]Hori S. Lineage stability and phenotypic plasticity of Foxp3 + regulatory T cells. Immunol Rev. (2014) 259: 159– 72. 10.1111/imr.12175 24712465 · DOI
  36. [47]Koenen HJPM Smeets RL Vink PM van Rijssen E Boots AMH Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells. Blood. (2008) 112: 2340– 52. 10.1182/blood-2008-01-133967 18617638 · DOI
  37. [48]Tsuji M Komatsu N Kawamoto S Suzuki K Kanagawa O Honjo T. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut peyer's patches. Science. 323: 1488– 92. 10.1126/science.1169152 19286559 · DOI
  38. [49]Murai M Turovskaya O Kim G Madan R Karp CL Cheroutre H. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. (2009) 10: 1178– 84. 10.1038/ni.1791 19783988 PMC2898179 · DOI
  39. [50]Zeng H Chi H. mTOR signaling and transcriptional regulation in T lymphocytes. Transcription. (2014) 5: e28263. 10.4161/trns.28263 25764218 PMC4214230 · DOI
  40. [51]Hooper LV Littman DR Macpherson AJ. Interactions between the microbiota and the immune system. Science. (2012) 336: 1268– 73. 10.1126/science.1223490 22674334 PMC4420145 · DOI · Paper page
  41. [52]Maes M Kubera M Leunis JC. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett. (2008) 29: 117– 24. 18283240
  42. [53]Alvarez-Mon MA Gómez AM Orozco A Lahera G Sosa MD Diaz D. Abnormal distribution and function of circulating monocytes and enhanced bacterial translocation in major depressive disorder. Front Psychiatry. (2019) 10: 812. 10.3389/fpsyt.2019.00812 31803077 PMC6873610 · DOI
  43. [54]Moreno-Navarrete JM Sabater M Ortega F Ricart W Fernández-Real JM. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE. (2012) 7: e37160. 10.1371/journal.pone.0037160 22629362 PMC3356365 · DOI
  44. [55]Albillos A. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. (2003) 37: 208– 17. 10.1053/jhep.2003.50038 12500206 · DOI
  45. [56]Kéri S Szabó C Kelemen O. Expression of toll-like receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain Behav Immun. (2014) 40: 235– 43. 10.1016/j.bbi.2014.03.020 24726793 · DOI · Paper page
  46. [57]Lui PP Cho I Ali N. Tissue regulatory T cells. Immunology. (2020) 161: 4– 17. 10.1111/imm.13208 32463116 PMC7450170 · DOI
  47. [58]Ohlsson L Gustafsson A Lavant E Suneson K Brundin L Westrin Å. Leaky gut biomarkers in depression and suicidal behavior. Acta Psychiatr Scand. (2019) 139: 185– 93. 10.1111/acps.12978 30347427 PMC6587489 · DOI
  48. [59]Gárate I Garcia-Bueno B Madrigal JLM Caso JR Alou L Gomez-Lus ML. Stress-induced neuroinflammation: role of the toll-like receptor-4 pathway. Biol Psychiatry. (2013) 73: 32– 43. 10.1016/j.biopsych.2012.07.005 22906518 · DOI · Paper page

Cited by

Sorted by citations

Authors
Alvarez-Mon, M. A., Gomez-Lahoz, A. M., Orozco, A., Lahera, G., Sosa-Reina, M. D., Diaz, D., Albillos, A., Quintero, J., Molero, P., Monserrat, J., & Alvarez-Mon, M.
Affiliations
  • Universidad de Alcalá (ES)
  • Hospital Universitario Príncipe de Asturias (ES)
  • Universidad Complutense de Madrid (ES)
  • Clinica Universidad de Navarra (ES)
Venue
Frontiers in Psychiatry
Published
2021-01-08
Volume
11
Pages
591962-591962
ISSN
1664-0640 (ISSN-L)
OpenAlex
W3119265583
Cited by
44
References
11
Citations by year
2025: 6 · 2024: 11 · 2023: 10 · 2022: 12 · 2021: 5
FWCI
3.54
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • e_Buah (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Instituto de Salud Carlos III
  • Comunidad de Madrid
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
major depressive disorder, regulatory T cells, bacterial translocation, intestinal barrier dysfunction, CD4+ T cell differentiation, CCR2, CCR6, IL-10, zonulin, intestinal fatty acid binding protein, LPS-binding protein, gut microbiota, neuroinflammation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review